Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predictive value of homologous recombination-related gene mutations in survival outcomes of first-line nivolumab plus chemotherapy for gastric cancer. | Gastric Cancer | 2025 | 40719786 | PubTator, text mining | PubMed |
| Surgical Choice among Women with a First Breast Cancer and Pathogenic Variants in Breast Cancer Genes. | Ann Surg Oncol | 2025 | 40717162 | PubTator, text mining | PubMed |
| Using the safety scissors: DNA resection regulation at DNA double-strand breaks and telomeres. | DNA Repair (Amst) | 2025 | 40716322 | PubTator, text mining | PubMed |
| konnect2prot 2.0: Integrating advanced analytical tools for deeper understanding of protein properties in a functional protein-protein interaction network. | Comput Struct Biotechnol J | 2025 | 40687990 | PubTator, text mining | PubMed |
| LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair Genes. | JCO Precis Oncol | 2025 | 40632975 | PubTator, text mining | PubMed |
| Pancreatic cancer organoids derived from EUS-guided fine needle aspiration specimens can be used to predict chemotherapy resistance. | Sci Rep | 2025 | 40610535 | PubTator, text mining | PubMed |
| LncRNA-Protein Interactions: A Key to Deciphering LncRNA Mechanisms. | Biomolecules | 2025 | 40563521 | PubTator, text mining | PubMed |
| BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient. | Gynecol Oncol Rep | 2025 | 40521346 | PubTator, text mining | PubMed |
| The prognostic and predictive value of homologous recombination deficiency in gastrointestinal cancer. | Oncologist | 2025 | 40515474 | PubTator, text mining | PubMed |
| Moderate-Low Risk Breast Cancer Gene Expression in a Romanian Population. | Int J Mol Sci | 2025 | 40508121 | PubTator, text mining | PubMed |
| Classification of Gene Variants in a Danish Population with Suspected Predisposition to Hereditary Breast and/or Ovarian Cancer. | Cancers (Basel) | 2025 | 40507299 | PubTator, text mining | PubMed |
| Comprehensive investigation of DNA damage repair genes in children with cancer identifies SMARCAL1 as novel osteosarcoma predisposition gene. | medRxiv | 2025 | 40463577 | PubTator, text mining | PubMed |
| Genomic landscape and homologous recombination repair deficiency signature in stage I-III and de novo stage IV primary breast cancers. | Oncologist | 2025 | 40421962 | PubTator, text mining | PubMed |
| Pan-cancer analysis of homologous recombination deficiency and homologous recombination repair-associated gene alterations in solid tumors from a large Asian cohort. | BMC Cancer | 2025 | 40420266 | PubTator, text mining | PubMed |
| MePCE promotes homologous recombination through coordinating R-loop resolution at DNA double-stranded breaks. | Cell Rep | 2025 | 40411785 | PubTator, text mining | PubMed |
| Cell-cycle dependent inhibition of BRCA1 signaling by the lysine methyltransferase SET8. | Cell Cycle | 2025 | 40405477 | PubTator, text mining | PubMed |
| Clinical genome sequencing in patients with hereditary breast and ovarian cancer: Concept, implementation and benefits. | Breast | 2025 | 40403485 | PubTator, text mining | PubMed |
| CTC1-STN1-TEN1 controls DNA break repair pathway choice via DNA end resection blockade. | Science | 2025 | 40403056 | PubTator, text mining | PubMed |
| Study on the molecular mechanism of UBA52 and BARD1 regulating hepatocellular carcinoma through the PI3 K/AKT signaling pathway. | Discov Oncol | 2025 | 40397202 | PubTator, text mining | PubMed |
| Phase II Study of Niraparib in Patients With Advanced Melanoma With Homologous Recombination Pathway Gene Mutations. | JCO Precis Oncol | 2025 | 40373259 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=8